Skip to main content

Table 4 Microvascular density levels at various levels of clinico-pathological variables. The adjacent table reports median MVD levels at different levels of clinico-pathological variables. None of the comparisons are statistically significant

From: Angiogenesis in male breast cancer

  Age group Tumor size Node status
  <65 years <65 years T1 T2 T3 Negative Positive
VWF               
   AMC 15.6 (5.7) 15.0 (5.8) 15.8 (5.5) 13.5 (5.3) 17.5 (27.9) 14.2 (5.2) 15.6 (5.2)
   CMC 53.7 (24.7) 47.2 (50.2) 44.8 (30.5) 50.3 (43.7) 67.5 (40.3) 48.5 (39.8) 50.0 (35.6)
   HMC 84.0 (50.3) 70.0 (48.5) 86.5 (48.6) 69.0 (58.5) 70.0 (41.8) 84.0 (53.5) 69.3 (44.0)
CD31               
   AMC 5.9 (20.9) 14.5 (28.8) 6.8 (28.6) 11.4 (30.5) 15.4 (61.7) 7.2 (17.9) 10.4 (32.6)
   CMC 18.8 (41.4) 26.2 (28.6) 15.7 (38.0) 29.3 (28.9) 20.7 (81.0) 17.9 (33.7) 32.5 (36.5)
   HMC 36.5 (44.8) 38.0 (27.0) 28.0 (40.0) 43.6 (22.3) 30.0 (107.4) 35.9 (40.0) 43.0 (42.6)
CD34               
   AMC 19.7 (9.6) 19.8 (10.5) 21.0 (9.0) 17.3 (11.5) 20.0 (81.8) 18.8 (8.3) 19.9 (11.4)
   CMC 52.0 (21.8) 41.3 (35.0) 43.3 (29.4) 52.0 (34.2) 48.5 (46.5) 47.2 (35.0) 50.7 (29.0)
   HMC 89.0 (50.5) 70.0 (77.0) 79.0 (54.3) 86.0 (83.1) 88.0 (79.2) 90.0 (63.3) 70.0 (60.9)
CD105               
   AMC 2.7 (4.4) 4.4 (4.3) 2.7 (3.8) 4.4 (5.4) 5.4 (10.0) 3.0 (4.7) 4.0 (3.6)
   CMC 8.8 (14.3) 10.7 (13.2) 7.0 (13.8) 10.9 (14.9) 14.3 (31.7) 9.2 (14.5) 10.2 (10.6)
   HMC 29.0 (24.5) 32.0 (34.5) 28.5 (30.3) 30.5 (49.3) 39.0 (156.0) 26.5 (33.0) 31.0 (20.0)
VEGF               
   AMC 7.5 (20.0) 17.9 (25.1) 11.9 (25.5) 15.4 (26.8) 5.8 (64.9) 13.4 (21.8) 13.2 (29.2)
   CMC 42.5 (47.0) 39.4 (33.6) 47.5 (72.9) 40.8 (39.5) 36.3 (45.6) 41.1 (45.1) 42.3 (58.8)
   HMC 58.8 (103.1) 80.0 (87.6) 70.3 (113.6) 66.0 (79.1) 80.0 (55.9) 69.8 (86.2) 79.0 (92.8)
  1. None of the differences between levels of age or clinico-pathological variables are statistically significant